Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 197
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3165
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 317
Function: require_once
98%
921
2 minutes
20
Extracellular vesicles (EVs) play an indispensable role in a variety of physiological and pathological processes, including embryonic development, cellular migration, and malignant transformation of tumors. Tumor-derived exosomes (TDEs) have emerged as a key component of the tumor microenvironment (TME), intricately involved in tumor growth, vascular permeability, and pre-metastatic niche (PMN) formation. Consequently, TDEs encapsulate bioactive molecules in their lumen, facilitating their delivery to distant microenvironments and inducing the reprogramming of specific cell types to establish PMNs. This, in turn, endows cancer cells with robust capabilities for growth, metastasis, and chemoresistance. In this review, we consolidate current research elucidating the role of small EVs in cancer progression, with a particular focus on cancer metastasis, and their therapeutic potential. In addition, we review novel exosome-based methods, such as single-EV profiling, which aim to open new avenues for cancer research, diagnosis, and treatment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ymthe.2025.07.016 | DOI Listing |